Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer

Onconix, Inc60 enrolled

Overview

The purpose of this study is to determine whether Insulin-like Growth Factor II is elevated sufficiently to detect Cervical Intraepithelial Neoplasia II (CIN II), Cervical Intraepithelial Neoplasia III (CIN III), and cervical cancer.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Cervical Cancer Cervical Intraepithelial Neoplasia II Cervical Intraepithelial Neoplasia III

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18 - 75 years * Female * Normal medical history * Medical history of a single type of cancer confirmed by biopsy or equivalent criteria * Squamous cell carcinoma of organs other than cervix * Adenocarcinoma * Medical history of inflammatory disease * May be pregnant * Pap smear positive for Cervical Intraepithelial Neoplasia II or III * Squamous cell cervical cancer confirmed by biopsy * Informed consent * Willingness to submit a blood sample by venipuncture * Willingness to submit a second blood sample if necessary Exclusion Criteria: * Age \< 18 or \> 75 years * Medical history of cancer other than cervical cancer, Non-islet-cell tumor hypoglycemia, Growth hormone deficiency, Acromegaly, Hepatoma, inflammatory disease in addition to confirmed CIN and cervical cancer

Locations (1)

Georgia Health Sciences

Augusta, Georgia, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.